Received Apr 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | EN6202 | IM / AR |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | EN6207 | IM / AR |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 3 | EW0183 | IM / AR |
PFIZER #1 3/16/2021 PFIZER #2 4/6/2021 PFIZER #3 1/11/2021 HAD INITIAL MILD GENERALIZED REACTION THEN 2022 DEVELOPED SOB DIAGNOSED WITH ALLERGIC ASTHMA HAD SEVERAL ED VISITS AND DEPENDENCE ON INHALERS. CHEST CT NEGATIVE. NO PFTS. SEVERAL COURSES OF ORAL STEROIDS. VACCINATION FAILED AND CONTRACTED COVID-19 SUSPECTED BUT NOT TESTED. IN 2024 CONGENITAL HEART BLOCK BECAME SYMPTOMATIC BRADYCARDIA AND HAD PPM INSERTED. DIAGNOSED WITH POST-COVID19 VACCINE INJURY SYNDROME INVOLVING THE PULMONARY AND CARDIOVASCULAR SYSTEM. 2026 SPIKE ABS >25,000.
NONE
CONGENITAL HEART BLOCK
NONE
MULTIPLE ENVIRONMENTAL ALLERGIES AND ANIMAL DANDER
EXAM, ECG, LABS, CHEST CT. TREATED WITH 90 DAYS IVM AND PROTOCOL BASE SPIKE DETOXIFICATION. Clinical Rationale for SARS-CoV-2 Base Spike Protein Detoxification in Post COVID-19 and Vaccine Injury Syndromes.